NPRC/Institute
Federal Medical-Biological Agency of Russia, Moscow, Russia and others
Summary of Study
Recombinant nucleocapsid-based vaccine Convacell®.
Year Published
2023
References
PMID: 37112786 / doi: 10.3390/vaccines11040874
Contact Info
Sevastyan Rabdano: sevastyan@rabdano.ru
Keywords
SARS-CoV-2, nucleocapsid (N) protein, vaccine, immune response, pathology, mice, hamsters, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type